mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
UNC0321 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.5 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.5 |